Neurodegeneration – News and Features

Sareum will apply its skills in high throughput protein expression, purification and structure determination.

Both Companies have achieved expression of significant quantities of the human protein, interferon beta-1a.

The work focuses on apoE4, one of three specific forms of apolipoprotein E, commonly known as apoE.

Technical advances promote uptake of biochips in clinical research applications.

Genzyme bought extensive gene therapy assets from US company Avigen in December.

Funds will be used for development of molecular imaging agents that identify and measure amyloid plaque.

Use of nanotechnology in medicine will make a major impact on healthcare in the 21st century.

Findings shows that myelin breakdown is a key contributor to the onset of Alzheimer disease.

The research provides evidence that RPI-78M modulates the expression of this gene in laboratory assays.

Compounds from natural products continue to be the important sources of completely new chemistry.